Anthony Gigon

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Combination Therapy

Age Related Macular Degeneration

Vascular Endothelial Growth Factor

Top Venues

Eye (London, England)

Medicina (Kaunas, Lithuania)

This page only lists publications with an associated author ORCID identifier.

Publications

Anthony Gigon, Antonio Iskandar, Sophie Kasser, Sacha Naso, Marta Zola, Irmela Mantel
Short-term response to anti-VEGF as indicator of visual prognosis in refractory age-related macular degeneration. Eye (London, England) 38 (7) (2024)
Anthony Gigon, Antonio Iskandar, Sophie Kasser, Sacha Naso, Marta Zola, Irmela Mantel
Short-term response to anti-VEGF as indicator of visual prognosis in refractory age-related macular degeneration. Eye (London, England) 38 (7) (2024)
Anthony Gigon, Antonio Iskandar, Sophie Kasser, Sacha Naso, Marta Zola, Irmela Mantel
Short-term response to anti-VEGF as indicator of visual prognosis in refractory age-related macular degeneration. Eye (London, England) (2024)
Anthony Gigon, Antonio Iskandar, Sophie Kasser, Sacha Naso, Marta Zola, Irmela Mantel
Short-term response to anti-VEGF as indicator of visual prognosis in refractory age-related macular degeneration. Eye (London, England) 38 (7) (2024)
Anthony Gigon, Antonio Iskandar, Sophie Kasser, Sacha Naso, Marta Zola, Irmela Mantel
Short-term response to anti-VEGF as indicator of visual prognosis in refractory age-related macular degeneration. Eye (London, England) 38 (7) (2024)
Anthony Gigon, Antonio Iskandar, Sophie Kasser, Sacha Naso, Marta Zola, Irmela Mantel
Short-term response to anti-VEGF as indicator of visual prognosis in refractory age-related macular degeneration. Eye (London, England) 38 (7) (2024)
Anthony Gigon, Maria Vadalà, Vincenza M E Bonfiglio, Michele Reibaldi, Chiara M Eandi
Early OCTA Changes of Type 3 Macular Neovascularization Following Brolucizumab Intravitreal Injections. Medicina (Kaunas, Lithuania) 58 (9) (2022)